Kazuhiko Yamamoto
Directeur/Membre du Conseil chez Bio Palette Co., Ltd.
Postes actifs de Kazuhiko Yamamoto
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Bio Palette Co., Ltd.
 Bio Palette Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Bio Palette Co., Ltd. provides genetic modification services for microbes, therapeutics and agriculture industries. The company was founded by Shoko Murase and Akihiko Kondo on February 21, 2017 and is headquartered in Kobe, Japan. | Directeur/Membre du Conseil | 01/02/2019 | - |
Synplogen Co., Ltd.
 Synplogen Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Synplogen Co., Ltd. is a synthetic biology startup that provides DNA synthesis and DNA library construction services using their proprietary DNA synthesis technologies OGAB™ and Combinatorial-OGAB. The company was founded in 2017 by Akihiko Kondo and Kenji Tsuge and is based in Kobe, Japan. The Japanese company also offers design, development, and analysis services for gene therapy products such as viral vectors through their Gene Therapy Biofoundry™ service. | Directeur/Membre du Conseil | 01/09/2018 | - |
Historique de carrière de Kazuhiko Yamamoto
Formation de Kazuhiko Yamamoto
| University of Hitotsubashi | Undergraduate Degree |
Statistiques
Internationale
| Japon | 4 |
Opérationnelle
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Commercial Services | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Bio Palette Co., Ltd.
Bio Palette Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Bio Palette Co., Ltd. provides genetic modification services for microbes, therapeutics and agriculture industries. The company was founded by Shoko Murase and Akihiko Kondo on February 21, 2017 and is headquartered in Kobe, Japan. | Commercial Services |
Synplogen Co., Ltd.
Synplogen Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Synplogen Co., Ltd. is a synthetic biology startup that provides DNA synthesis and DNA library construction services using their proprietary DNA synthesis technologies OGAB™ and Combinatorial-OGAB. The company was founded in 2017 by Akihiko Kondo and Kenji Tsuge and is based in Kobe, Japan. The Japanese company also offers design, development, and analysis services for gene therapy products such as viral vectors through their Gene Therapy Biofoundry™ service. | Commercial Services |
- Bourse
- Insiders
- Kazuhiko Yamamoto
- Expérience
